NCT02691351

Intercontinental Cooperative Non-Hodgkin T-cell Lymphoma Prospective Registry Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 500 (actual)
• Sponsor: Samsung Medical Center · Academic / Other
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

The better understanding of non-Hodgkin T-cell lymphoma is essential for establishing effective treatment strategy for non-Hodgkin T-cell lymphoma. Therefore, the data about conical features and treatment outcomes of each subtype should be accumulated to establish treatment strategy. However, the majority of previous data for non-Hodgkin T-cell lymphoma was from small case series of single institute. Furthermore, as novel drugs were developed for the treatment of relapsed or refractory T-cell lymphoma, the date from patients who were treated with those novel drugs are especially required because their outcomes may reflect the outcomes of currently available treatments. Thus, a multinational, multicenter prospective registry study is needed to provide information useful for establishing treatment strategies for T-cell lymphoma.

Conditions

• Non-Hodgkin T-cell Lymphoma

Interventions

Type	Name	Description
OTHER	Prospective Registry	Survival and disease status follow-up at 1st primary treatment, 1st salvage treatment and 2nd salvage treatment 1. Regimen 2. Response Evaluation 3. SUSAR(Suspected, Unexpected, Serious, Adverse Reaction) collection

Timeline

• Start date: 2016-03-01
• Primary completion: 2020-07-01
• Completion: 2020-09-01
• First posted: 2016-02-25
• Last updated: 2020-09-09

Locations

1 site across 1 country: South Korea